Ensayos clínicos

8.676 ensayos encontrados

CompletadoFase 2ClinicalTrials.gov

A 6-month Randomized, Double-blind, Parallel-group, Multicentre, Placebo-controlled Phase II Study to Compare Anti-asthmatic Effect and Safety of Esomeprazole (Nexium®) 40 mg Twice Daily or 40 mg Once Daily With Placebo in Adults With Asthma

INTERVENTIONALInicio: 1 de abr de 2006ID: NCT00317044

CompletadoFase 3ClinicalTrials.gov

A Phase III, Randomized Multi-centre, Double-blind, Parallel Group, Active Comparator Study to Compare the Efficacy and Safety of SPD476 (Mesalazine)2.4g/Day Once Daily With Asacol 1.6g/Day Twice Daily in the Maintenance of Remission in Patients With Ulcerative Colitis

INTERVENTIONALInicio: 8 de abr de 2005ID: NCT00151892

TerminadoFase 2ClinicalTrials.gov

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multiple-Dose Phase 2 Study to Evaluate the Efficacy and Safety of BMS-986263 in Adults With Compensated Cirrhosis From Nonalcoholic Steatohepatitis (NASH)

INTERVENTIONALInicio: 17 de mar de 2021ID: NCT04267393

DesconocidoClinicalTrials.gov

International Multicenter Prospective, Non-competitive, Observational Study to Validate and Optimize Prediction Models of 90-day and 1-year Allograft Failure After Liver Transplantation

OBSERVATIONALInicio: 1 de abr de 2022ID: NCT05289609

RetiradoClinicalTrials.gov

Estudio RioplateNsE Sobre Telemonitoreo en hIpertensos No-controlAdos

INTERVENTIONALInicio: 1 de dic de 2016ID: NCT02730052

CompletadoFase 3ClinicalTrials.gov

A Randomized, Double-Blind, Parallel Study of Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD)

INTERVENTIONALInicio: 1 de feb de 2008ID: NCT00658775

ReclutandoFase 3ClinicalTrials.gov

A Phase 2b/3 Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Protocol to Evaluate the Efficacy and Safety of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

INTERVENTIONALInicio: 3 de oct de 2025ID: NCT07196722

ReclutandoClinicalTrials.gov

Effect of Consumption of a Milk Product Designed for Lactating Women on Human Milk Composition and Nutritional Status of Iron and DHA in Infant Red Blood Cells.. Study in a Vulnerable Population.

INTERVENTIONALInicio: 1 de jun de 2024ID: NCT06319079

CompletadoFase 2ClinicalTrials.gov

Antiviral Effect, Safety and Pharmacokinetics of BI 201335 NA in Hepatitis C Virus Genotype 1 Infected Treatment-naïve and Treatment-experienced Patients for 24 Weeks as Combination Therapy With Pegylated Interferon-alpha 2a and Ribavirin (Double-blinded, Randomised, Placebo-controlled, Phase II)

INTERVENTIONALInicio: 1 de oct de 2008ID: NCT00774397

CompletadoFase 3ClinicalTrials.gov

A Randomised, Double-blind, Placebo-controlled, Parallel Group Study to Determine the Effect of 12 Weeks Treatment of Orally Inhaled Tiotropium + Olodaterol Fixed Dose Combination (2.5/5 µg and 5/5 µg) Delivered by the Respimat® Inhaler, on Exercise Endurance Time During Constant Work Rate Cycle Ergometry in Patients With Chronic Obstructive Pulmonary Disease (COPD)[Torracto (TM)]

INTERVENTIONALInicio: 1 de feb de 2012ID: NCT01525615

DesconocidoClinicalTrials.gov

Incidence of de Novo Hepatocellular Carcinoma After Direct-acting Antiviral Agents for HCV: a Multicenter Prospective Cohort Study From Latin America.

OBSERVATIONALInicio: 1 de may de 2016ID: NCT03775798

CompletadoFase 4ClinicalTrials.gov

Effect of the Endopeptidase AN-PEP on Gluten Exposure in Real Life in Celiac Disease Patients Treated With a Long-term Gluten-free Diet. Exploratory, Interventional, Prospective, Controlled and Double Blind Study

INTERVENTIONALInicio: 17 de mar de 2021ID: NCT04788797

ReclutandoFase 2ClinicalTrials.gov

A Phase 1B/2 Pan-Tumor, Open-Label Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02)

INTERVENTIONALInicio: 10 de abr de 2024ID: NCT06330064

Activo, no reclutaFase 3ClinicalTrials.gov

A Phase 3, Multicenter, Randomized, Efficacy Assessor-Blinded Study of Risankizumab Compared to Ustekinumab for the Treatment of Adult Subjects With Moderate to Severe Crohn's Disease Who Have Failed Anti-TNF Therapy

INTERVENTIONALInicio: 30 de sept de 2020ID: NCT04524611

DesconocidoClinicalTrials.gov

Effectiveness of Implementing a Strategy to Re-linkage to Care of Patients With Hepatitis C Who Were Lost to Follow-up

OBSERVATIONALInicio: 1 de sept de 2020ID: NCT04470271

ReclutandoFase 3ClinicalTrials.gov

A Phase III, Multicenter, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Induction Therapy With RO7790121 in Patients With Moderately to Severely Active Ulcerative Colitis

INTERVENTIONALInicio: 11 de dic de 2024ID: NCT06588855

CompletadoFase 3ClinicalTrials.gov

A Multicenter, Randomized, Blinded Efficacy and Safety Study of Pasireotide LAR vs Octreotide LAR in Patients With Metastatic Carcinoid Tumors Whose Disease-related Symptoms Are Inadequately Controlled by Somatostatin Analogues.

INTERVENTIONALInicio: 1 de abr de 2008ID: NCT00690430

CompletadoFase 2ClinicalTrials.gov

Randomized Phase 2 Trial Evaluating Pharmacokinetics and Safety of Four Ramucirumab Dosing Regimens in Second-Line Gastric or Gastroesophageal Junction Adenocarcinoma

INTERVENTIONALInicio: 7 de jul de 2015ID: NCT02443883

TerminadoFase 3ClinicalTrials.gov

Parallel-Group Treatment, Double-Blind, 2-Arm to Investigate Comparative Efficacy Safety Immunogenicity Between Intravenous AVT16 and Entyvio® in Male and Female Subjects 18 to 80 Years Inclusive, Moderate to Severe Ulcerative Colitis

INTERVENTIONALInicio: 23 de sept de 2024ID: NCT06570772

TerminadoFase 2ClinicalTrials.gov

Randomised, Open-label and Parallel Group Trial to Investigate the Effects of Oral BI 685509 Alone or in Combination With Empagliflozin on Portal Hypertension After 8 Weeks Treatment in Patients With Clinically Significant Portal Hypertension (CSPH) in Compensated Cirrhosis

INTERVENTIONALInicio: 28 de jun de 2022ID: NCT05282121